Tempus AI, Inc. Class A Common Stock

Tempus AI, Inc. Class A Common Stock

$39.76
2.26 (6.03%)
NASDAQ
USD, US
Healthcare

52 Week Range

22.89-43.88

Beta

0

Market Cap

$6.55B

Last Dividend

0

PE (TTM)

Dividend Yield (TTM)

Price Chart

Industry

Healthcare

Sector

Healthcare

CEO

Mr. Eric P. Lefkofsky

IPO Date

2012-03-28

Description

Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.

Phone

(800) 976-5448

Address

600 West Chicago Avenue, Chicago, IL, 60654, US

CIK